痰热清注射液联合头孢哌酮舒巴坦治疗老年社区获得性肺炎50例临床观察

陈洪伟; 向希; 赵志冬

doi:10.13898/j.cnki.issn.1000-2200.2019.02.012

痰热清注射液联合头孢哌酮舒巴坦治疗老年社区获得性肺炎50例临床观察

Clinical effect of Tanreqing injection combined with cefoperazone sulbactam in the treatment of elderly community acquired pneumonia in 50 cases

摘要

摘要:
目的观察痰热清注射液联合头孢哌酮舒巴坦治疗老年社区获得性肺炎的临床疗效。
方法收集老年社区获得性肺炎、中医辨证为风温肺热病痰热阻肺证者50例，随机分成观察组与对照组，各25例，对照组给予头孢哌酮舒巴坦静滴，观察组在对照组的基础上加用痰热清注射液，疗程为14 d。观察病人治疗前后主要临床症状、体征及胸部X线片变化。
结果观察组疗效优于对照组（P < 0.05）；观察组临床症状、体征恢复时间较对照组缩短（P < 0.05~P < 0.01），胸部X线片示观察组炎症病灶完全吸收率高于对照组（P < 0.05）。
结论痰热清注射液联合头孢哌酮舒巴坦治疗老年社区获得性肺炎疗效好，大大缩短病程，且未发现明显不良反应。

Abstract:
ObjectiveTo observe the clinical effects of Tanreqing injection combined with cefoperazone sulbactam in the treatment of elderly community acquired pneumonia.
MethodsFifty elderly community acquired pneumonia cases, with wind warm lung heat disease phlegm heat obstructie pulmonary syndrome, were randomly divided into the treatment group and control group(25 cases each group).The control group were intravenously treated with cefoperazone sulbactam, and the treatment group was additionally treated with Tanreqing injection based on the control group for 14 days.The main clinical symptoms, signs and X-ray of chest in two groups before and after treatment were observed.
ResultsThe difference of treatment effect between two groups was not statistically significant(P>0.05).The recovery time of the clinical symptoms and signs in treatment group was shorter than that in control group(P < 0.05 to P < 0.01), and the result of chest X-ray showed that the absorption rate of inflammatory lesion in treatment group was higher than that in control group(P < 0.05).
ConclusionsThe treatment of elderly community acquired pneumonia with Tanreqing injection combined with cefoperazone sulbactam has good effect, short course, and no obvious side reaction.

HTML全文

参考文献(5)

施引文献

资源附件(0)